TCL Archive Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival March 28, 2014
TCL Archive UCSD Center Designated Comprehensive; Siteman Center In St. Louis Wins Core Grant. August 31, 2001